HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuhua Shang Selected Research

Glucagon-Like Peptide-1 Receptor

11/2014Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double-blind, placebo-controlled, 24-week trial (GetGoal-M-Asia).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuhua Shang Research Topics

Disease

4Type 2 Diabetes Mellitus (MODY)
06/2021 - 11/2014
2Body Weight (Weight, Body)
01/2018 - 11/2014
1Hypoglycemia (Reactive Hypoglycemia)
06/2021
1Weight Loss (Weight Reduction)
11/2014
1Nausea
11/2014
1Hypertension (High Blood Pressure)
01/2012
1Hyperlipidemias (Hyperlipidemia)
01/2012
1Fabry Disease (Fabry's Disease)
11/2004
1Proteinuria
11/2004

Drug/Important Bio-Agent (IBA)

2Insulin Glargine (Lantus)FDA Link
06/2021 - 01/2020
2Insulin (Novolin)FDA Link
01/2020 - 01/2018
2lixisenatideIBA
01/2018 - 11/2014
1Hypoglycemic Agents (Hypoglycemics)IBA
06/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Glucagon-Like Peptide-1 ReceptorIBA
11/2014
1Metformin (Glucophage)FDA LinkGeneric
11/2014
1HDL CholesterolIBA
01/2012
1LDL CholesterolIBA
01/2012
1Triglycerides (Triacylglycerol)IBA
01/2012
1alpha-Galactosidase (Beano)IBA
11/2004
1CreatinineIBA
11/2004
1Proteins (Proteins, Gene)FDA Link
11/2004

Therapy/Procedure

1Glycemic Control
06/2021